3 documents found, page 1 of 1

Sort by Issue Date

Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in ...

Figueiredo, A; Almeida, M A; Almodovar, M T; Alves, P; Araújo, A; Araújo, D; Barata, F; Barradas, L; Barroso, A; Brito, U; Camacho, E; Canário, D

OBJECTIVE: The main aim of the study was to evaluate the efficacy and safety profile of Nivolumab, an immune-checkpoint-inhibitor antibody, in advanced, previously treated, Non-Small Cell Lung Cancer (NSCLC) patients, in a real world setting. METHODS: We performed a retrospective, multicentre data analysis of patients who were included in the Portuguese Nivolumab Expanded Access Program (EAP). Eligibility crite...

Date: 2020   |   Origin: Saúde - CUF

Hiperplasia Difusa do Timo Após Quimioterapia a Doença de Hodgkin

Moreira, JR; Brito, U; Rosado, J; Gaspar, L; Soromenho, F

Os autores descrevem um caso de um doente de 23 anos com linfoma de 1-Iodgkin de celularidade mista num estádio II-B que após quimioterapia desenvolveu uma massa mediastínica, cuja histologia revelou tratar-se de uma hiperplasia do timo.


Diffuse hyperplasia of the thymus after chemotherapy for Hodgkin's disease.

Moreira, J R; Brito, U; Rosado, J; Gaspar, L; Soromenho, F

Date: 1992   |   Origin: Acta Médica Portuguesa

3 Results

Queried text

Refine Results

Author





















Date



Document Type


Access rights


Resource




Subject